|
|
||||||||
J Thorac Cardiovasc Surg 2005;129:1177-1178
© 2005 The American Association for Thoracic Surgery
Brief Communications |
a University of Illinois College of Medicine at Peoria
b Department of Surgery, Peoria, Ill
c Section of Cardiothoracic Surgery, Peoria, Ill.
Received for publication July 22, 2004; accepted for publication August 23, 2004. * Address for reprints: Richard C. Anderson, MD, FACS, University of Illinois College of Medicine at Peoria, Department of Surgery, North Building, 2nd Floor, 624 NE Glen Oak Ave, Peoria, IL 61603-3135.
Renal cell carcinoma is neither uncommon nor easy to detect. For this reason, coupled with the highly vascular nature of this tumor, it is frequently discovered incidentally or through workup of a metastasis. Literature from 19721 and 19812 detail 3 patients who underwent both nephrectomy and sternal resection for a metastatic renal cell carcinoma and were asymptomatic after 5 years. Since that time, written material on the topic of isolated renal cell metastases has been sparse. Given the current state of prosthetic materials and surgical expertise, in the presence of an isolated metastatic lesion to the sternum, resection and reconstruction with intent to palliate or obviate disease is preferred. We report on our experience with one case of a singular metastatic focus in the sternum and the sternectomy and reconstruction used in treatment.
Clinical summary
A 47-year-old woman had pain overlying the sternum. Clinical examination at that time showed a tender protuberance with fullness across the manubrium and proximal sternum. Computed tomography of the chest and abdomen was obtained and revealed a 2.2 x 4.5cm sternal mass (Figures 1 and 2) and a 5.8 x 6.4cm left renal hilar mass invading the left renal vein. A subsequent positron emission tomographic scan showed hypermetabolism in the kidney and sternum. Biopsy of the sternal mass was performed, and pathology revealed metastatic renal cell carcinoma. Given that she showed no overt or radiologic signs of other lesions, the patient underwent left nephrectomy and was prepared for sternal resection and reconstruction.
|
Six months after sternal resection and reconstruction, the patient has maintained excellent range of motion without instability.
Discussion
Renal cell carcinoma accounts for approximately 3% of adult malignancies, with about 1 of 4 presenting with metastases, 95% of which are multiple.3 When the diagnosis involves disease in the sternum, resection and reconstruction with a rigid prosthesis has been shown to provide both palliation and prolonged survival.4 By using Prolene, Marlex C.R. Bard, Inc, Billerica, Mass), or Vicryl (Ethicon) nets or Gore-Tex (W. L. Gore & Associates, Inc, Flagstaff, Ariz) patches and a rigid support, one prevents postoperative paradoxical movement of the chest wall while providing adequate precordial protection. In addition, sternal metastases are different from other bony metastases, such as vertebral metastases, in that their lack of an expansive communicative vasculature, like those provided by the paravertebral venous plexus and other venous systems, means they might remain solitary for an extended time.5
When, in 1966, Drs Yale and Wear continued a challenge to the old thinking that resections of sternal metastases were futile, they admitted that the sometimes long dormant nature of renal cell carcinoma ought to steer one away from pronouncing a cure with resection.2 Even then, however, in the absence of todays technology, removing the tumor was the best way to prolong and preserve a high quality of life. Additional benefit comes from active research regarding the use of immunotherapy. Such therapy, when combined with a means of reducing tumor bulk, can provide significant symptomatic relief.
In this case our patient presented with renal cell carcinoma invading the renal vein and a concurrent but isolated lesion in the midline anterior chest wall. We elected to perform sternal resection and reconstruction with a Prolene methylmethacrylate sandwich, achieved good fixation intraoperatively, and, after a 7-day hospital course and 6 months after the operation, the patient is doing very well.
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |